Prolonged Anticoagulation With Apixaban Found Beneficial In Venous Thromboembolism

Prolonged Anticoagulation With Apixaban Found Beneficial In Venous Thromboembolism: A new study suggests that extending anticoagulant therapy for an additional year may be beneficial after patients with venous thromboembolism complete their initial course of therapy. The results of AMPLIFY-EXT (Apixaban after the Initial Management of Pulmonary Embolism and Deep Vein Thrombosis with First-Line Therapy-Extended Treatment) were presented at the annual meeting of the American Society of Hematology meeting in Atlanta and published simultaneously in the New England Journal of  Medicine.